- Home
- PVH vs AXSM Comparison
PVH vs AXSM Comparison
Compare PVH & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVH
- AXSM
- Stock Information
- Founded
- PVH 1881
- AXSM 2012
- Country
- PVH United States
- AXSM United States
- Employees
- PVH N/A
- AXSM N/A
- Industry
- PVH Apparel
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- PVH Consumer Discretionary
- AXSM Health Care
- Exchange
- PVH Nasdaq
- AXSM Nasdaq
- Market Cap
- PVH 6.1B
- AXSM 6.3B
- IPO Year
- PVH N/A
- AXSM 2015
- Fundamental
- Price
- PVH $64.46
- AXSM $116.79
- Analyst Decision
- PVH Buy
- AXSM Strong Buy
- Analyst Count
- PVH 16
- AXSM 14
- Target Price
- PVH $114.88
- AXSM $168.93
- AVG Volume (30 Days)
- PVH 1.3M
- AXSM 588.7K
- Earning Date
- PVH 03-31-2025
- AXSM 05-05-2025
- Dividend Yield
- PVH 0.23%
- AXSM N/A
- EPS Growth
- PVH 45.85
- AXSM N/A
- EPS
- PVH 12.35
- AXSM N/A
- Revenue
- PVH $8,771,200,000.00
- AXSM $385,693,000.00
- Revenue This Year
- PVH N/A
- AXSM $65.06
- Revenue Next Year
- PVH $0.20
- AXSM $63.84
- P/E Ratio
- PVH $5.24
- AXSM N/A
- Revenue Growth
- PVH N/A
- AXSM 42.53
- 52 Week Low
- PVH $62.94
- AXSM $64.11
- 52 Week High
- PVH $141.15
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- PVH 33.37
- AXSM 42.02
- Support Level
- PVH $65.41
- AXSM $117.60
- Resistance Level
- PVH $67.35
- AXSM $122.97
- Average True Range (ATR)
- PVH 2.44
- AXSM 4.23
- MACD
- PVH 0.60
- AXSM -1.27
- Stochastic Oscillator
- PVH 23.59
- AXSM 19.70
About PVH PVH Corp.
PVH designs and markets branded apparel in more than 40 countries. Its key fashion categories include men's dress shirts, ties, sportswear, underwear, and jeans. Its two designer brands, Calvin Klein and Tommy Hilfiger, now generate practically all its revenue after its recent disposition of most of its smaller brands. PVH operates e-commerce sites and about 1,500 stores, licenses its brands to third parties, and distributes its merchandise through department stores and other wholesale accounts. The firm traces its history to 1881 and is based in New York City.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.